Concepedia

Michael Amantea

MA

Statistics

Publications

24

Citations

2K

H-Index

21

Active since

1988

Affiliations

National Institutes of Health(Current)

Pfizer (United States)

National Institutes of Health Clinical Center

Millard Fillmore Suburban Hospital

Sunesis (United States)

Michael Amantea is an author at National Institutes of Health specializing in pharmacology, pharmacy, and pharmacokinetics.

Publications per year

1988–2020

24

Publications

24

Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma

Donald W. Northfelt, Francis J. Martin, Peter K. Working et al. · The Journal of Clinical Pharmacology · 1996 · 376 citations

, , +14

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice

Mary S. Newman, Gail Colbern, Peter K. Working et al. · Cancer Chemotherapy and Pharmacology · 1999 · 274 citations

, , +17

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits

J W Lee, Michael Amantea, Peter Francis et al. · Antimicrobial Agents and Chemotherapy · 1994 · 135 citations · Full text

, , +14

Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis

Alan Forrest, Sanford Chodosh, Michael Amantea et al. · Journal of Antimicrobial Chemotherapy · 1997 · 130 citations · Full text

, , +13

Safety and pharmacokinetics of fluconazole in children with neoplastic diseases

J W Lee, Nita L. Seibel, Michael Amantea et al. · The Journal of Pediatrics · 1992 · 120 citations

, , +10

1–5 of 24